Sign in

Applonia Rose

@apploniarose.bsky.social
134 followers 466 following 5 posts

Editor of Technology in Cancer Research & Treatment (Impact Factor: 2.7; Q2 in Oncology - Scopus & Scimago rankings).

PostsRepliesMedia
Applonia Rose @apploniarose.bsky.social · 06/05/2026
I'll be attending #ESTRO2026 next week!! A great chance to engage with the radiation oncology community and explore emerging directions. I'm representing TCRT @tcrtcancer.bsky.social and particularly keen to connect with our board members and authors. Happy to connect if you’ll be there.
021
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 10/04/2026
A new study in Technology in Cancer Research & Treatment explores PET-guided radiotherapy under varying uptake conditions, revealing key insights into its real-world reliability and limits. journals.sagepub.com/doi/10.1177/... @journals.sagepub.com #Radiotherapy #PET #MedicalPhysics #Imaging
032
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 09/01/2026
Starting the new year by highlighting the clinical impact of research published in TCRT! @tcrtcancer.bsky.social View TCRT articles cited in clinical guidelines: journals.sagepub.com/page/tct/art... Happy New Year! @journals.sagepub.com #CancerResearch #ClinicalGuidelines #Oncology #OncoDaily
011
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 22/09/2025
Read the latest Editorial published in TCRT @tcrtcancer.bsky.social - The Bharat Cancer Genome Atlas: Charting India's Unique Cancer Landscape for Precision Oncology journals.sagepub.com/doi/10.1177/... @vinodscaria.bsky.social @karkinoshealth.bsky.social #CancerGenomics #PrecisionOncology
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
054
Reposted by Applonia Rose
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 14/08/2025
Brain tumors consist of cells in successive stages of activation. Researchers at DKFZ and @uniheidelberg.bsky.social have discovered a signaling protein that could keep the cancer cells in a dormant state - with the hope of halting tumor growth. #Glioblastoma t1p.de/mbmec
t1p.de
Freezing brain tumor cells in a dormant state
Every brain tumor is made up of cells in successive stages of activation. Researchers at the German Cancer Research Center (DKFZ) and Heidelberg University have now analyzed the individual structure o...
063
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 14/08/2025
Newly published in TCRT@tcrtcancer.bsky.social: Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems doi.org/10.1177/1533... @journals.sagepub.com @oncodaily.bsky.social #LungCancer #CancerResearch #EarlyDetection
doi.org
Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems - Anu Maria Sebastian, David Peter, T. P. Rajagopal, Rinu Ann Sebastian, 2025
Introduction Lung cancer has the highest mortality rate among all cancer types globally, largely due to delayed or ineffective diagnosis and treatment. Radiomic...
033
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 11/08/2025
📢 New in TCRT @tcrtcancer.bsky.social: Researchers from #UTSouthwestern & RefleXion tested biology-guided radiotherapy (BgRT) beyond lung & bone cancers, creating PET-based plans for multiple cancer sites using RefleXion X1 with SCINTIX® tech, and all deemed clinically acceptable. bit.ly/45bUulJ
bit.ly
Expanding SCINTIX Biology-Guided Radiotherapy Beyond Lung and Bone: A Planning Feasibility and Dosimetric Study on the RefleXion X1 System - Haozhao Zhang, Grant Gibbard, Chenyang Shen, Thomas I. Bank...
Introduction SCINTIX® therapy, a form of biology-guided radiotherapy using real-time positron emission tomography (PET) imaging on the RefleXion® X1 platform, r...
032
Applonia Rose @apploniarose.bsky.social · 01/08/2025
New article published in @tcrtcancer.bsky.social shows how transcriptomic-based prognostic tests can improve recurrence risk prediction in papillary thyroid cancer. @journals.sagepub.com Read the full article here: bit.ly/3ITzE1P #ThyroidCancer #MolecularDiagnostics #CancerBiomarkers #OncoDaily
033
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 30/07/2025
Why publish with Technology in Cancer Research & Treatment? @tcrtcancer.bsky.social 🔍Researchers value our fair and efficient review process. Hear directly from authors about their experience: bit.ly/457bwQF @journals.sagepub.com #CancerResearch #Oncology #OpenAccess #OncoDaily
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
032
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 15/07/2025
New in @tcrtcancer.bsky.social: A Translational Research Leveraging Diagnostic Accuracy of Innovations in MRI as a Model for Early Breast Cancer Detection in Uganda. #BreastCancer #MRI #CancerResearch #OncoDaily Read the article here: journals.sagepub.com/doi/10.1177/...
journals.sagepub.com
A Translational Research Leveraging Diagnostic Accuracy of Innovations in MRI as a Model for Early Breast Cancer Detection in Uganda - Alfred Bulamu, Gregory S. Karczmar, Funmi Olopade, Zhen Ren, Vice...
Introduction Breast cancer remains a leading cause of cancer-related morbidity and mortality in sub-Saharan Africa, with Uganda experiencing a reported 5% annua...
012
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 14/07/2025
New in @tcrtcancer.bsky.social: A novel HER2-targeted nanoliposome therapy shows promise in overcoming immunotherapy resistance in HER2+ breast cancer by turning “cold” tumors hot. Read here: bit.ly/451i7gH @journals.sagepub.com #CancerResearch #BreastCancer #Immunotherapy #HER2 #OncoDaily
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
012
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 08/07/2025
Electrochemotherapy for Anorectal Tumors: A Narrative Literature Review @tcrtcancer.bsky.social @journals.sagepub.com #CancerResearch #Oncology #Electrochemotherapy #AnorectalCancer #CancerTreatment #openaccess journals.sagepub.com/doi/10.1177/...
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
121
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 03/07/2025
Join TCRT as a Section Editor! Make an impact in Cancer Biology, Detection, Diagnosis & Treatment. 🌟 IF 2.8 | Q2 Oncology | 600K+ downloads/year |500+ Board members Read more: bit.ly/4lBVOn9 Apply here: bit.ly/4nu0eye @tcrtcancer.bsky.social @drjkyl.bsky.social @journals.sagepub.com #Oncology
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
032
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 19/06/2025
#CallForPapers #LiverCancer #AIinMedicine #SurgicalInnovation #OncologyResearch #MedicalTechnology #AcademicPublishing #LiverSurgery #XRinHealthcare #3DPrinting #Metabolomics #FutureofMedicine @apploniarose.bsky.social @drjkyl.bsky.social @editorsimrun.bsky.social
051
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 19/06/2025
New Review published in @tcrtcancer.bsky.social explores the role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy. #CancerResearch #Lymphoma #Oncology #Radiotherapy @journals.sagepub.com @oncodaily.bsky.social journals.sagepub.com/doi/full/10....
journals.sagepub.com
The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review - Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, Luca Trigg...
Introduction Historically, the management of relapsed or refractory diffuse large B-cell lymphoma (r/r-DLBCL) involved chemotherapy and autologous stem cell tra...
033
Applonia Rose @apploniarose.bsky.social · 18/06/2025
🎉 Exciting news! @tcrtcancer.bsky.social TCRT is now ranked Q2 in Oncology (new IF is 2.8) in the latest JCR - a first for us! Huge thanks to our authors, editors & reviewers for making it happen. @sagepub.com Keep advancing cancer research with us: bit.ly/43QY0Bm #Oncology #CancerResearch
bit.ly
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
021
Applonia Rose @apploniarose.bsky.social · 28/05/2025
⏱️ Time Matters in Radiotherapy Delays in treatment can affect patient outcomes and clinic operations. A new review in @tcrtcancer.bsky.social maps where time is lost and how streamlining workflows can improve care. Read the article: journals.sagepub.com/doi/10.1177/... #Radiotherapy #Oncology
journals.sagepub.com
Time Matters: A Review of Current Radiotherapy Practices and Efficiency Strategies - Sibel Karaca, Meltem Kırlı Bölükbaş, 2025
Radiotherapy is a multi-step process that includes planning, contouring, simulation, patient assessment, quality control, and treatment. Each step must be compl...
010
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 27/05/2025
New systematic review published in @tcrtcancer.bsky.social explores Percutaneous Locoregional Therapies for the Treatment of Liver Metastases from Uveal Melanoma. Read the article here: doi.org/10.1177/1533... @journals.sagepub.com @University of Catania #MelanomaAwareness #InterventionalOncology
doi.org
Percutaneous Locoregional Therapies for the Treatment of Liver Metastases from Uveal Melanoma: A Systematic Review - Corrado Ini', Pietro Valerio Foti, Renato Farina, Francesco Tiralongo, Davide Giuse...
Introduction The prognosis of patients with uveal melanoma is related to several factors, including local or extraocular extension of the disease. Up to 50% of ...
022
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 23/05/2025
New research published in @tcrtcancer.bsky.social presents a dose kernel-based spot scanning approach for hypofractionated brain radiosurgery, offering precise and efficient treatment. @keck.usc.edu @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #RadOnc #GammaKnife #Radiosurgery
032
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 23/05/2025
🔬 New #CallForPapers from Tech in Cancer Research & Treatment! We're spotlighting imaging in women’s health, from biopsies to MRI to tumoroids. If you're working on novel or gold-standard imaging in female cancer research, we want to hear from you. Guest Editor: Dr Anna Schueth
122
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 21/05/2025
New Review published in @tcrtcancer.bsky.social explores miR-10b as a Clinical Marker and Therapeutic Target in Breast Cancer. @michiganstateu.bsky.social @journals.sagepub.com Read the full article here: journals.sagepub.com/doi/full/10.... #CancerResearch #BreastCancer #OncologyResearch
032
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 19/05/2025
Saliva spectroscopy to differentiate smokers: New study in @tcrtcancer.bsky.social uses FTIR on dried saliva to spot differences in bound water across smoking groups—offering a path to explore links to oral cancer risk. 🔗 journals.sagepub.com/doi/10.1177/... #OralHealth #Spectroscopy #TCRT
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
022
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 07/05/2025
🔊New review in @tcrtcancer.bsky.social explores combining Cetuximab with immune checkpoint inhibitors to treat MSS/pMMR colorectal cancer. Read the full article here: bit.ly/3GKmVgP @journals.sagepub.com #ColorectalCancer #Immunotherapy #Cetuximab #OncologyResearch #Oncology
023
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 30/04/2025
📢 New review article published in @tcrtcancer.bsky.social explores the genetic and epidemiological landscape of various cancers in Arab populations. Read the full article here: journals.sagepub.com/doi/10.1177/... @journals.sagepub.com #CancerGenomics #ArabWorld #PrecisionMedicine #GlobalHealth
042
Reposted by Applonia Rose
Technology in Cancer Research & Treatment (IF 2.8) @tcrtcancer.bsky.social · 28/04/2025
📢A brand new look for TCRT! We've refreshed our look to highlight the core areas we publish in: cancer biology, detection, diagnosis & prognosis, and treatment. Curious to learn more about who we are and what we publish? Find out here journals.sagepub.com/overview-met... #Oncology #CancerResearch
062
Applonia Rose @apploniarose.bsky.social · 24/04/2025
New research in TCRT @tcrtcancer.bsky.social identifies pathogenic BRCA1/2 variants in Nigerian breast cancer patients, highlighting the need for genetic screening. bit.ly/4m3eX2L; bit.ly/42uWdBr @solomonrotimi.bsky.social @journals.sagepub.com #BreastCancer #Genetics #CancerResearch
bit.ly
Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients - Abimbola F. Onyia, Paul Jibrin, Temitope Olatunji-Agunbiade, Ademola Oyekan, AbdulRazzaq Lawal, Adewumi Alabi, Antho...
Background Breast cancer remains a leading cause of mortality among Nigerian women, with triple-negative breast cancer (TNBC) being particularly prevalent. Vari...
042